These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18973849)

  • 1. Combining non-invasive methods for assessment of liver fibrosis.
    Bourlière M; Pénaranda G; Adhoute X; Oules V; Castellani P
    Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):73-9. PubMed ID: 18973849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.
    Sebastiani G; Halfon P; Castera L; Mangia A; Di Marco V; Pirisi M; Voiculescu M; Bourliere M; Alberti A
    Aliment Pharmacol Ther; 2012 Jan; 35(1):92-104. PubMed ID: 22035045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis.
    Boursier J; Vergniol J; Sawadogo A; Dakka T; Michalak S; Gallois Y; Le Tallec V; Oberti F; Fouchard-Hubert I; Dib N; Rousselet MC; Konaté A; Amrani N; de Ledinghen V; Calès P
    Liver Int; 2009 Nov; 29(10):1507-15. PubMed ID: 19725892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.
    Sebastiani G; Vario A; Guido M; Noventa F; Plebani M; Pistis R; Ferrari A; Alberti A
    J Hepatol; 2006 Apr; 44(4):686-93. PubMed ID: 16490278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
    Castéra L; Sebastiani G; Le Bail B; de Lédinghen V; Couzigou P; Alberti A
    J Hepatol; 2010 Feb; 52(2):191-8. PubMed ID: 20006397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
    Castera L
    J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients.
    Miailhes P; Pradat P; Chevallier M; Lacombe K; Bailly F; Cotte L; Trabaud MA; Boibieux A; Bottero J; Trepo C; Zoulim F
    J Viral Hepat; 2011 Jan; 18(1):61-9. PubMed ID: 20196798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
    Castéra L; Le Bail B; Roudot-Thoraval F; Bernard PH; Foucher J; Merrouche W; Couzigou P; de Lédinghen V
    J Hepatol; 2009 Jan; 50(1):59-68. PubMed ID: 19013661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive evaluation of liver fibrosis using transient elastography.
    Castera L; Forns X; Alberti A
    J Hepatol; 2008 May; 48(5):835-47. PubMed ID: 18334275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients.
    Bourliere M; Penaranda G; Ouzan D; Renou C; Botta-Fridlund D; Tran A; Rosenthal E; Wartelle-Bladou C; Delasalle P; Oules V; Portal I; Castellani P; Lecomte L; Rosenthal-Allieri MA; Halfon P
    Aliment Pharmacol Ther; 2008 Aug; 28(4):458-67. PubMed ID: 18498446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients.
    Beckebaum S; Iacob S; Klein CG; Dechêne A; Varghese J; Baba HA; Sotiropoulos GC; Paul A; Gerken G; Cicinnati VR
    Transplantation; 2010 Apr; 89(8):983-93. PubMed ID: 20335832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of fibrosis and cirrhosis. Liver biopsy is not always necessary.
    Prescrire Int; 2010 Feb; 19(105):38-42. PubMed ID: 20455345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease.
    Castera L
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):291-303. PubMed ID: 21497746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical application of non-invasive diagnosis for hepatic fibrosis].
    Cho SW; Cheong JY
    Korean J Hepatol; 2007 Jun; 13(2):129-37. PubMed ID: 17585186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
    Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
    J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers.
    Sánchez-Conde M; Montes-Ramírez ML; Miralles P; Alvarez JM; Bellón JM; Ramírez M; Arribas JR; Gutiérrez I; López JC; Cosín J; Alvarez E; González J; Berenguer J
    J Viral Hepat; 2010 Apr; 17(4):280-6. PubMed ID: 19732322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy?
    Castera L; Bedossa P
    Liver Int; 2011 Jan; 31 Suppl 1():13-7. PubMed ID: 21205132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive assessment of chronic liver and gastric diseases.
    Plebani M; Basso D
    Clin Chim Acta; 2007 May; 381(1):39-49. PubMed ID: 17374528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.
    Boursier J; de Ledinghen V; Zarski JP; Fouchard-Hubert I; Gallois Y; Oberti F; Calès P;
    Hepatology; 2012 Jan; 55(1):58-67. PubMed ID: 21898504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.
    Patel K; Gordon SC; Jacobson I; Hézode C; Oh E; Smith KM; Pawlotsky JM; McHutchison JG
    J Hepatol; 2004 Dec; 41(6):935-42. PubMed ID: 15582126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.